Status:
COMPLETED
Economic Analysis of Robotic Rectal Resection in German Health Care System
Lead Sponsor:
Universitätsklinikum Hamburg-Eppendorf
Conditions:
Rectal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Analysis of cost effectiveness of robotic rectal resection, either sphincter preserving or abdominoperineal extirpation, in the German diagnosis related groups (DRG) system.
Detailed Description
Robotic surgery has many well-known benefits for patients and surgeons, while it comes with higher acquisition and maintenance costs. On the other hand, a higher proportion of minimally invasive proce...
Eligibility Criteria
Inclusion
- 18y
- histologically proven rectal cancer with curative therapeutic approach
- suitable for minimally-invasive surgery
Exclusion
- no rectal cancer
- primary open surgery
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
65 Patients enrolled
Trial Details
Trial ID
NCT06113796
Start Date
January 1 2018
End Date
December 31 2021
Last Update
November 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Hamburg Medical Institutions
Hamburg, Germany